Background: Although most Dutch women plan their pregnancy, less then half begin using folic acid supplements before they become pregnant.
Introduction
Periconceptional folic acid supplementation reduces the risk of neural tube defects by more than 50%.
1, 2 Therefore, Dutch women planning a pregnancy are advised to take folic acid tablets from four weeks before conception until eight weeks after. 3 Current and recent programmes to increase periconceptional folic acid use may leave at least 50% and as many as 80% unprotected from the beneficial effects of folic acid. 4, 5 Since fortification of staple food with folic acid is currently not allowed in the Netherlands, 6 consumption of folic acid supplements is the only means of sufficiently increasing the daily intake of folic acid. Because over 80% of Dutch women plan their pregnancy, 7 there is an opportunity to plan folic acid consumption. However, the problem remains of how to reach this target group with information about folic acid before they attempt to get pregnant. Since approximately 70% of Dutch women take oral contraceptives at some time before their first pregnancy and therefore visit their pharmacy regularly, folic acid information could be provided in the community pharmacy. In the Netherlands, oral contraceptives are always obtained from a pharmacy and patients visit only one pharmacy.
We therefore developed a programme in Dutch community pharmacies which aimed to inform and motivate women using oral contraceptives to start taking folic acid supplements a few weeks before they attempt to become pregnant. The aim of the study was to evaluate the effect of the information on women's knowledge and attitudes and in particular among those planning a pregnancy.
Methods
The setting for the study was a small Dutch town (approximately 80,000 inhabitants). Of its nine community pharmacies, one was excluded because one of the researchers (RAJ) is employed there and another could not participate due to organisational changes. The remaining seven pharmacies all agreed to participate and were randomly assigned as intervention (n=4) or reference (n=3) pharmacies. The intervention took place from February to July 2002 and consisted of adding stickers about folic acid on the boxes of Oral contraceptives dispensed during the study period with the text: "Are you planning to have a baby? Ask for information about folic acid in your pharmacy." Additionally the intervention pharmacies were asked to give a leaflet about folic acid at least once to every woman with a prescription for oral contraceptives during the intervention period. The implementation of the intervention is described in detail elsewhere. 8 Six months after the intervention a random sample of women, who had received an oral contraceptive during the study period, received The questionnaire asked if the woman had been pregnant before, and whether they were either currently pregnant or planning to become pregnant, and also asked the woman's age. There were questions about the respondents' knowledge (the beneficial effects of folic acid and when to take folic acid), attitude (would they advise other women to take folic acid) and behaviour (whether they were taking or would take folic acid when pregnant or attempting to conceive). The questionnaire also asked about sources of information about folic acid (see figure 1 ).
Data Analysis
P-values were calculated with chi-square tests. Sub analyses were performed on the questionnaires of women with definite plans to become pregnant. The level of significance was set as p of 0.05 or lower. The results are presented as percentages and percentage differences per group. towards greater knowledge of the protective effects of folic acid in the intervention group.
The between-group differences for intervention and reference groups were 2.3% for nulligravidae and 12.0% for gravidae. In the intervention group, a higher percentage could state the correct period of use (4.7% and 5.9% difference between the groups for nulligravidae and gravidae respectively). Most respondents knew that folic acid should be started before pregnancy (these groups included the respondents who stated the correct period of use).
The pharmacy (pharmacist or technician), leaflets and other professionals were reported more often as sources of information by women in the intervention group. Leaflets were mentioned by 146 (40%) of women in the intervention and 12% in the reference group. The pharmacy was mentioned by 38 (10%) of women in the intervention and 4 (2%) in the reference group. Apart from the source 'other professionals" among the nulligravidae, these differences were all significant. It was not possible to determine whether the respondent was referring to the leaflet received as part of the intervention because the questionnaire did not specifically ask about that leaflet and any others. More women in the intervention group said they would recommend the use of folic acid to other women compared with the reference Chapter 10 136 group. The between-group differences for intervention and reference were 11.7% and 7.7%
for nulligravidae and gravidae, although these differences were not statistically significant.
Among women planning to become pregnant in the next year (table 3) , knowledge about beneficial effects and about correct period of use of folic acid was higher in the intervention group compared with the reference group. For knowing the correct period of use, this difference was significant among the gravidae. The percentages for knowledge in this subgroup were also higher compared to all responders (table 2) . Current use of folic acid among women planning a pregnancy was higher in the intervention group compared with the reference group (62.5 vs. 30.8% in nulligravidae and 40.0% vs. 26.7% in gravidae).
Among the nulligravidae planning a pregnancy, current use, intention to use, and not intending to use all differed significantly between the intervention and reference groups (p=0.02).
Discussion
Women who received information about folic acid with their oral contraceptives seemed to have greater knowledge about, a more positive attitude towards and higher intention to use folic acid compared with women who did not receive this information. The differences were most evident for nulligravidae and for those who intended to conceive within the next 12 months. Since in the Netherlands no wide spread preconception care is available, these two groups are considered the most difficult to reach. Women in the intervention group were three times more likely to mention a leaflet as a source of information about folic acid and five times more likely to mention the pharmacy as were women in the reference group. Our data strongly suggest that information about folic acid provided from community pharmacies with an opportunity for discussion with pharmacists and technicians can reach and inform women who are planning to become pregnant. Among these women, the use of folic acid and future intention to use folic acid was significantly higher in the intervention group.
Although, as expected, the proportion of women who knew about folic acid was higher in the group that had been pregnant before, our results indicate that continued education is still needed among this group.
Although some of the differences between intervention and reference groups were significant, some were not. The largest limitation of the study, being a pilot study, was that it might have been under-powered to detect differences between sub-groups, especially because we felt it was necessary to present the results for the nulligravidae and gravidae separately, some of the cell sizes were small. All women in the intervention group should Improved periconceptional folic acid use after patient education in pharmacies 137 have received both a sticker on their oral contraceptives and a leaflet about folic acid.
Although the majority recalled the former, only around half said they had received the leaflet.
Thus the delivery of the intervention was not uniform across the group. A small number of women in the reference group reported receiving a sticker and/or leaflet with their oral contraceptives. If this had influenced the results of the study, we believe our results are an underestimation of the possible reachable effect if all women in the intervention group had received full education. The response rate of over 60% was good, but another weakness of the study is that we have no information on non-responders to the questionnaire. Although it could be argued that women interested in the subject would be more likely to respond to the questionnaire, we do not believe that the differences between the groups could be attributed to this.
The most important outcome was whether women planning a pregnancy or in the early stages of pregnancy were actually taking folic acid. Our results indicate that positive effects for this outcome variable can be achieved. Among the nulligravidae we found a significant difference in use and intentional use. During their first pregnancy Dutch women usually visit their midwife or physician in week 10, when the neural tube is already closed and when information on folic acid comes too late. Involving pharmacists and technicians to inform and stimulate women to take folic acid before they become pregnant seems to add to the awareness and use of folic acid. Further studies with larger numbers of pharmacies are now needed to further evaluate the effects. In the Netherlands this approach will now be rolled out to pharmacies across the country and the effects will be measured on a larger scale.
Furthermore we believe that this approach is also applicable in other countries and we would encourage others to test it.
Conclusion
Community pharmacies can provide targeted information to women who are planning to become pregnant. This study showed that providing information about folic acid from pharmacies to women using oral contraceptives has the potential to increase awareness and use of folic acid among women planning to become pregnant.
